Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,765.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 2,902.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 74,268
  • Market Cap: £1,165.46m
  • RiskGrade: 128

Dividend Data

  30-Jun-2330-Jun-2230-Jun-2130-Jun-2030-Jun-19
Interim Dividend10.30p10.30p10.30p9.40p8.90p
Final Dividend21.70p21.70p21.70p19.70p18.80p
Total Dividend32.00p32.00p32.00p29.10p27.70p
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing Operations          
Revenue 689.70 593.40 574.30 551.40 488.50
Operating Profit/(Loss) 40.50 49.40 47.70 42.40 8.70
Net Interest (14.30) (6.20) (5.00) (5.00) (3.90)
Profit Before Tax 39.40 48.40 55.80 46.30 9.90
Profit After Tax 31.80 36.70 46.80 35.70 6.70
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 31.80 36.70 46.80 35.70 6.70
Attributable to:          
Equity Holders of Parent Company 33.30 40.90 47.30 35.30 7.80
Minority Interests (1.50) (4.20) (0.50) 0.40 (1.10)
           
Continuing EPS          
Earnings per Share - Basic 50.80p 62.50p 72.60p 54.40p 12.40p
Earnings per Share - Diluted 50.50p 62.20p 72.00p 54.00p 11.90p
Earnings per Share - Adjusted 84.80p 82.70p 100.90p 77.30p 73.20p
Continuing and Discontinued EPS          
Earnings per Share - Basic 50.80p 62.50p 72.60p 54.40p 12.40p
Earnings per Share - Diluted 50.50p 62.20p 72.00p 54.00p 11.90p
Earnings per Share - Adjusted 84.80p 82.70p 100.90p 77.30p 73.20p
           
Dividend per Share 32.00p 32.00p 32.00p 29.10p 27.70p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 164.40 171.40 402.90 428.00 373.10
Intangible Assets 174.00 183.00 157.80 168.50 186.40
Investment Properties n/a n/a n/a n/a n/a
Investments 53.50 41.20 48.80 6.90 31.00
Other Financial Assets n/a n/a n/a n/a 0.40
Other Non-Current Assets 356.60 364.80 9.80 28.20 3.50
  748.50 760.40 619.30 631.60 594.40
Current Assets          
Inventories 61.30 50.90 37.00 37.40 36.00
Trade & Other Receivables 136.10 133.50 108.80 100.80 98.00
Cash at Bank & in Hand 36.30 38.80 46.00 41.30 30.50
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 25.30 34.30 39.90 44.30 44.70
  259.00 257.50 231.70 223.80 209.20
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,007.50 1,017.90 851.00 855.40 803.60
           
Liabilities          
Current Liabilities          
Borrowings 4.20 7.10 22.90 19.20 4.30
Other Current Liabilities 143.00 144.20 119.60 111.00 99.90
  147.20 151.30 142.50 130.20 104.20
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 217.90 206.60 128.70 124.70 105.80
Provisions 61.50 72.30 64.10 77.30 72.40
Other Non-Current Liabilities 13.70 15.60 19.10 28.70 34.10
  293.10 294.50 211.90 230.70 212.30
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 440.30 445.80 354.40 360.90 316.50
           
Net Assets 567.20 572.10 496.60 494.50 487.10
           
Capital & Reserves          
Share Capital 6.60 6.60 6.60 6.50 6.50
Share Premium Account 179.10 179.10 179.10 179.10 179.00
Other Reserves 28.60 52.20 (8.00) 29.20 35.90
Retained Earnings 360.60 340.60 320.40 280.70 267.00
Shareholders Funds 574.90 578.50 498.10 495.50 488.40
           
Minority Interests/Other Equity (7.70) (6.40) (1.50) (1.00) (1.30)
Total Equity 567.20 572.10 496.60 494.50 487.10
Cash Flow 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Net Cash Flow From Operating Activities 50.40 34.30 67.50 60.10 33.40
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (30.90) (67.20) (46.70) (25.00) (46.10)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (18.20) 21.90 (14.20) (23.10) 13.60
Net Increase/Decrease In Cash 1.30 (11.00) 6.60 12.00 0.90
Ratios - based on IFRS 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing Operations          
PE Ratio - Adjusted 25.5 30.3 49.2 45.7 36.2
PEG - Adjusted 12.8 n/a 1.6 7.6 n/a
Earnings per Share Growth - Adjusted 2% -18% 30% 6% -4%
Dividend Cover 2.65 2.58 3.15 2.66 2.64
Revenue per Share 1,052.06p 907.41p 8.90p 849.51p 773.66p
Pre-Tax Profit per Share 60.10p 74.01p 0.86p 71.33p 15.68p
Operating Margin 5.87% 8.32% 8.31% 7.69% 1.78%
Return on Capital Employed 7.93% 8.09% 0.11% 9.37% 2.86%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 25.5 30.3 4,870.0 45.7 36.2
PEG - Adjusted 12.8 0.0 n/a 7.6 n/a
Earnings per Share Growth - Adjusted 2% 8,020% -99% 6% -4%
Dividend Cover 2.65 2.58 0.03 2.66 2.64
           
Dividend Yield 1.5% 1.3% 0.6% 0.8% 1.0%
Dividend per Share Growth n/a n/a 9.97% 5.05% 6.54%
Operating Cash Flow per Share 76.88p 52.45p 103.67p 92.59p 52.90p
Cash Incr/Decr per Share 1.98p (16.82p) 0.10p 18.49p 1.43p
Net Asset Value per Share (exc. Intangibles) 599.78p 595.00p 520.37p 502.25p 476.24p
Net Gearing 32.32% 30.23% 21.20% 20.71% 16.30%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page